DOUBLE-BLIND STUDY OF A SPASMOLYTIC-SEDATIVE FORMULATION.
D001285:Atropine; D001463:Barbiturates; D001965:Bromides; D004311:Double-Blind Method; D004378:Duodenal Diseases; D004381:Duodenal Ulcer; D004941:Esophagitis; D005756:Gastritis; D006801:Humans; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D010424:Pentobarbital; D010634:Phenobarbital; D010919:Placebos; D012601:Scopolamine; D013276:Stomach Ulcer
D001463:Barbiturates; D001965:Bromides; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D010919:Placebos; D001285:Atropine; D012601:Scopolamine; D010424:Pentobarbital; D010634:Phenobarbital
ATROPINE; BARBITURATES; BROMIDES; DUODENAL DISEASES; DUODENAL ULCER; ESOPHAGITIS; GASTRITIS; HYPNOTICS AND SEDATIVES; MUSCLE RELAXANTS; PENTOBARBITAL; PHENOBARBITAL; PLACEBOS; SCOPOLAMINE; STOMACH ULCER